Cyclin A is associated with an unfavourable outcome in patients with non-small cell lung carcinomas

British Journal of Cancer

Volumn 75, Issue 12, 1997, Pages 1774-1778

  Volm, M ^a   Koomagi R ^a   Mattern, J ^a   Stammler, G ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cyclin A; Drug response; Immunohistochemistry; Non small cell lung carcinomas; Prognosis; Survival

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CYCLIN A; DOXORUBICIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL CYCLE S PHASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME;

EID: 8244226661     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.302     Document Type: Article

References (14)

1. Abel U, Berger J and Wiebelt H (1984) Critlevel: an exploratory procedure for the evaluation of quantitative prognostic factors. Methods Inform Med 23: 154-156
2. Carr DT and Mountain CF (1977) Staging lung cancer. In Lung Cancer Clinical Diagnosis and Treatment. Strauss MJ. (ed.), pp. 151-161. Grune and Stratton: New York
3. Cordon-Cardo C (1995) Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia (Review). Am J Pathol 147: 545-560
4. Dutta A, Chandra R, Leiter L and Lester S (1995) Cyclins as marker of tumor proliferation: immunocytochemical studies in breast cancer. Proc Natl Acad Sci USA 92: 5386-5390
5. Fleiss JL (1973) Statistical Methods for Rates and Proportion. John Wiley: New York
6. Group for Sensitivity Testing of Tumors (KSST) (1981) In vitro short-term test to determine the resistance of human tumours to chemotherapy. Cancer 48: 2127-2135
7. Hartsough MT, Frey RS, Zipfel PA, Buard A, Cook SJ, McCormick F and Mulder KM (1996) Altered transforming growth factor β signaling in epithelial cells when ras activation is blocked. J Biol Chem 37: 22368-22375
8. Inohara S and Kitano Y (1994) Immunohistochemical detection of cyclin D and cyclin A in human hyperproliferative epidermis. Arch Dermatol Res 286: 504-506
9. Paterlini P, Flejou JF, De Mitri MS, Pisi E, Franco D and Brechot C (1995) Structure and expression of the cyclin A gene in human primary liver cancer. Correlation with low cytometric parameters. J Hepatol 23: 47-52
10. Volm M, Brüggemann A, Günther M, Kleine W, Pfleiderer A and Vogt-Schaden M (1985) Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma. Cancer Res 45: 5180-5185
11. Volm M, Hahn EW, Mattern J, Müller T, Vogt-Moykopf I and Weber E (1988) Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma. Cancer Res 48: 2923-2928
12. Volm M, Mattern J and Samsel B (1993) Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein; and glutathione S-transferase-π in human lung tumors. Cancer 71: 3181-3187
13. World Health Organization (1981) Histological typing of lung tumors. Tumori 6: 233-272
14. Zindy F, Lamas E, Chenivesse X, Sobczak I, Wang I, Fesquet D, Henglein B and Brechot C (1992) Cyclin A is required in S-phase in normal epithelial cells. Biochem Biophys Res Comm 182: 1144-1151